Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Chewable TabletRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2/3
1
50%
Not Applicable
1
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2/3Combined phases
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2/3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Completed(1)

Detailed Status

Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
Phase 2/3

Trials by Phase

Phase 2/31 (50.0%)
N/A1 (50.0%)

Trials by Status

completed150%
not_yet_recruiting150%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruitingphase_2_3

A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation

NCT06836024
completednot_applicable

Effectiveness of Calcium and Vitamin D, With and Without Collagen Peptide, in Enhancing Bone Mineral Density on Postmenopausal Women With Osteopenia

NCT06464718

Clinical Trials (2)

Showing 2 of 2 trials
NCT06836024Phase 2/3

A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation

Not Yet Recruiting
NCT06464718Not Applicable

Effectiveness of Calcium and Vitamin D, With and Without Collagen Peptide, in Enhancing Bone Mineral Density on Postmenopausal Women With Osteopenia

Completed

All 2 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
2